Employers saw their healthcare premiums rise 5% this year — and some passed on that burden to workers — as the cost of family coverage in job-based insurance exceeds $28,000 for family plans.
The "KFF Health News Minute" brings original healthcare and health policy reporting from our newsroom to the airwaves each week.
The Trump administration pushed back a rule — until after the midterm elections — that would complicate Americans’ access to less expensive medication imports from Canada and other countries.
The Trump administration has tied billions in rural health funding for states partly to the policy commitments they make, including ending their certificate of need, or CON, laws governing the construction of new hospitals.
Most of Georgia’s counties are without a labor and delivery unit. To fill the gap, the state is looking to equip emergency rooms to handle obstetric emergencies. Advocates and doctors worry, however, that the ER is being used as a stopgap.
Oregon passed a law to require hospitals to proactively screen patients to see if they qualify for financial aid. Patients got immediate relief. Hospitals pushed to roll back the law following federal cuts to Medicaid and Affordable Care Act subsidies.
A year after launching an inquiry into companies, including Deloitte, that receive billions in taxpayer dollars to build complex computer systems determining Medicaid eligibility, senators are urging the federal government to impose stricter rules.
As people take a greater number of medications across years or decades, experts say the risk for adverse drug interactions increases. One way to advocate for yourself? Keep a list of your meds handy.
The rapid emergence of the Chinese biotech industry has panicked U.S. politicians, but investors and patients caution that a clampdown on pharmaceutical collaboration could hurt everyone.
The anti-fraud efforts highlight a broader political fight ahead of the midterms. Republicans say they’re protecting taxpayer dollars by going after bad actors. Democrats contend the administration is — with insufficient evidence — targeting blue states to cut programs the GOP has long sought to shrink.
